Cargando…
Dual targeting of vascular endothelial growth factor and bone morphogenetic protein‐9/10 impairs tumor growth through inhibition of angiogenesis
Clinical development of anti‐angiogenic agents has been a major landmark in cancer therapy for several types of cancers. Signals mediated by both vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP)‐9 and 10 have been implicated in tumor angiogenesis. However, previous stud...
Autores principales: | Akatsu, Yuichi, Yoshimatsu, Yasuhiro, Tomizawa, Taishi, Takahashi, Kazuki, Katsura, Akihiro, Miyazono, Kohei, Watabe, Tetsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5276835/ https://www.ncbi.nlm.nih.gov/pubmed/28133920 http://dx.doi.org/10.1111/cas.13103 |
Ejemplares similares
-
Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1
por: Akatsu, Yuichi, et al.
Publicado: (2019) -
Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis
por: Miyazaki, Hideki, et al.
Publicado: (2014) -
TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2020) -
Emerging roles of inflammation-mediated endothelial–mesenchymal transition in health and disease
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2022) -
Roles of TGF-β
Signals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2011)